Thomas D. Salus's most recent trade in Lifecore Biomedical Inc was a trade of 37,000 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 08 Jul 2025 | 37,000 | 333,000 | - | - | Performance-Based Restricted Stock Units | ||
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 08 Jul 2025 | 37,000 | 252,000 (0%) | 0% | - | Common Stock | ||
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 08 Jul 2025 | 11,022 | 240,978 (0%) | 0% | 8.2 | 90,270 | Common Stock | |
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 14 Apr 2025 | 370,000 | 0 | - | - | Performance-Based Restricted Stock Units | ||
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 14 Apr 2025 | 210,000 | 210,000 | - | - | Incentive Stock Option (Right to Buy) | ||
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 14 Apr 2025 | 170,000 | 215,000 (0%) | 0% | - | Common Stock | ||
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | 14 Apr 2025 | 45,000 | 45,000 (0%) | 0% | - | Common Stock |